103 related articles for article (PubMed ID: 31238677)
1. Correlation between integration of high-risk HPV genome into human DNA detected by molecular combing and the severity of cervical lesions: first results of the EXPL-HPV-002 study.
Bouchilloux S; Fer F; Lemée F; Barradeau S; Dvorak V; Kubickova S; Ventruba P; Tachezy R; Trnková M; Janda P; Abscheidt J; Annibal E; El Mhali D; Garcia F; Kech M; Pilger G; Bensimon A; Mahé F
Ceska Gynekol; 2019; 84(2):84-92. PubMed ID: 31238677
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
4. Triage by HPV-DNA testing: is it useful in women with persistent minor smear abnormalities?
Pisal N; Sindos M; Chow C; Singer A
Acta Obstet Gynecol Scand; 2003 Jun; 82(6):575-7. PubMed ID: 12780430
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
6. Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
Sláma J; Dvořák V; Trnková M; Skřivánek A; Hurdálková K; Ovesná P; Nováčková M
Ceska Gynekol; 2020; 85(6):368-374. PubMed ID: 33711896
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
Castle PE; Eaton B; Reid J; Getman D; Dockter J
J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
[TBL] [Abstract][Full Text] [Related]
9. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study].
Kahng J; Lee HJ
Korean J Lab Med; 2008 Feb; 28(1):70-8. PubMed ID: 18309258
[TBL] [Abstract][Full Text] [Related]
12. Comparative Study of Cytology and Histopathology of Cervical Lesion in VIA Positive Patients and Its Correlation with High Risk Human Papilloma Virus.
Ansari NP; Saleh FM; Shahida SM; Rahman EN
Mymensingh Med J; 2017 Jul; 26(3):505-513. PubMed ID: 28919602
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
[TBL] [Abstract][Full Text] [Related]
14. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
15. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
16. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
17. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
18. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
Lefeuvre C; Pivert A; Guillou-Guillemette HL; Lunel-Fabiani F; Veillon P; Le Duc-Banaszuk AS; Ducancelle A
J Infect; 2020 Aug; 81(2):248-254. PubMed ID: 32413363
[TBL] [Abstract][Full Text] [Related]
19. An observational study of women with positive HPV-DNA tests and normal cytology and colposcopy.
Paraskevaidis E; Davidson EJ; Malamou-Mitsi V; Hirsch PM; Pappa L; Koliopoulos G; Lolis E; Zikopoulos K; Paschopoulos M; Doussias V; Agnantis N
Eur J Gynaecol Oncol; 2002; 23(4):320-2. PubMed ID: 12214732
[TBL] [Abstract][Full Text] [Related]
20. Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation.
Gardella B; Dominoni M; Pasquali MF; Gotti M; Fraticelli S; Lucioni M; Cesari S; Fiandrino G; De Silvestri A; Zerbi C; Lazic T; Arcaini L; Paulli M; Spinillo A
Gynecol Obstet Invest; 2024; 89(2):95-102. PubMed ID: 38262378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
